Market Overview

Boston Scientific Buys Rhythmia Medical; Sees Immaterial in FY13 and FY14

Share:
Related BSX
Boston Scientific Posts In-Line Q1 Earnings, Issues Weak Outlook
Earnings Scheduled For April 28, 2015
Boston Scientific's (BSX) CEO Mike Mahoney on Q1 2015 Results - Earnings Call Transcript (Seeking Alpha)

Boston Scientific Corporation (NYSE: BSX) has entered into a definitive agreement to acquire privately-held Rhythmia Medical, Inc., a developer of next-generation mapping and navigation solutions for use in cardiac catheter ablations and other electrophysiology procedures, including atrial fibrillation and atrial flutter.  Rhythmia Medical is based in Burlington, MA.  The transaction is expected to close by Friday, October 12^th.

Posted-In: News M&A

 

Related Articles (BSX)

Around the Web, We're Loving...